DD296924A5 - Antipoden-trennungsverfahren fuer 3r(3-carboxybenzyl)-6-(5-fluor-2-benzothiazolye) methoxy-4r-chromanol - Google Patents

Antipoden-trennungsverfahren fuer 3r(3-carboxybenzyl)-6-(5-fluor-2-benzothiazolye) methoxy-4r-chromanol Download PDF

Info

Publication number
DD296924A5
DD296924A5 DD90343216A DD34321690A DD296924A5 DD 296924 A5 DD296924 A5 DD 296924A5 DD 90343216 A DD90343216 A DD 90343216A DD 34321690 A DD34321690 A DD 34321690A DD 296924 A5 DD296924 A5 DD 296924A5
Authority
DD
German Democratic Republic
Prior art keywords
salt
fluoro
methoxy
quinine
chromanol
Prior art date
Application number
DD90343216A
Other languages
German (de)
English (en)
Inventor
Robert C Friedmann
George J Quallich
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD296924A5 publication Critical patent/DD296924A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD90343216A 1989-08-04 1990-08-02 Antipoden-trennungsverfahren fuer 3r(3-carboxybenzyl)-6-(5-fluor-2-benzothiazolye) methoxy-4r-chromanol DD296924A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/389,715 US4987231A (en) 1989-08-04 1989-08-04 Optical resolution method for 3R-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4R-chromanol

Publications (1)

Publication Number Publication Date
DD296924A5 true DD296924A5 (de) 1991-12-19

Family

ID=23539421

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90343216A DD296924A5 (de) 1989-08-04 1990-08-02 Antipoden-trennungsverfahren fuer 3r(3-carboxybenzyl)-6-(5-fluor-2-benzothiazolye) methoxy-4r-chromanol

Country Status (23)

Country Link
US (1) US4987231A (ja)
EP (1) EP0411813A1 (ja)
JP (1) JPH0374384A (ja)
KR (1) KR920011021B1 (ja)
CN (1) CN1024550C (ja)
AU (1) AU613838B2 (ja)
CA (1) CA2022611C (ja)
CZ (1) CZ279737B6 (ja)
DD (1) DD296924A5 (ja)
EG (1) EG19125A (ja)
FI (1) FI92826C (ja)
HU (1) HUT58734A (ja)
IE (1) IE902805A1 (ja)
IL (1) IL95213A (ja)
MY (1) MY105933A (ja)
NO (1) NO903420L (ja)
NZ (1) NZ234761A (ja)
PH (1) PH26568A (ja)
PL (1) PL164164B1 (ja)
PT (1) PT94888A (ja)
RU (1) RU1834889C (ja)
YU (1) YU47369B (ja)
ZA (1) ZA916126B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59198471A (ja) * 1983-04-26 1984-11-10 Canon Inc 複写装置
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
US5539128A (en) * 1994-11-30 1996-07-23 Pfizer Inc. Processes and intermediates for preparing cis(+)3-[4,6-dihydroxy chroman-3-ylmethyl]-4-methoxyaniline
DE102014010979B3 (de) 2014-07-29 2015-11-05 Sew-Eurodrive Gmbh & Co Kg Verwendung eines Anzeigemittels eines Umrichters, Verfahren zum Betreiben eines Umrichters und Umrichter

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA739471B (en) * 1972-12-22 1974-08-28 Hoffmann La Roche Chromane derivatives
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
MX13485A (es) * 1987-10-19 1993-05-01 Pfizer Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos

Also Published As

Publication number Publication date
PL164164B1 (pl) 1994-06-30
AU6019190A (en) 1991-02-07
CN1024550C (zh) 1994-05-18
CA2022611C (en) 1999-03-23
CA2022611A1 (en) 1991-02-05
MY105933A (en) 1995-02-28
PL286327A1 (en) 1991-03-25
FI92826B (fi) 1994-09-30
AU613838B2 (en) 1991-08-08
US4987231A (en) 1991-01-22
HU904892D0 (en) 1991-01-28
NO903420D0 (no) 1990-08-03
HUT58734A (en) 1992-03-30
YU152290A (sh) 1992-09-07
FI92826C (fi) 1995-01-10
IL95213A0 (en) 1991-06-10
EG19125A (en) 1994-07-30
PH26568A (en) 1992-08-19
IE902805A1 (en) 1991-02-27
KR920011021B1 (ko) 1992-12-26
FI903861A0 (fi) 1990-08-03
IL95213A (en) 1995-01-24
ZA916126B (en) 1992-03-25
YU47369B (sh) 1995-01-31
NO903420L (no) 1991-02-05
EP0411813A1 (en) 1991-02-06
KR910004610A (ko) 1991-03-29
CN1049160A (zh) 1991-02-13
RU1834889C (ru) 1993-08-15
PT94888A (pt) 1991-04-18
JPH0374384A (ja) 1991-03-28
NZ234761A (en) 1991-09-25
CZ279737B6 (cs) 1995-06-14

Similar Documents

Publication Publication Date Title
DE2902466C2 (ja)
DD145531A5 (de) Verfahren zur auftrennung von mischungen aus(+)-und(-)-6-methoxy-a-methyl-2-naphthalinessigsaeure und deren salzen
DE2358297C2 (de) Verfahren zur Gewinnung von reinem 3,3,7,7-Tetrahydroxymethyl-5-oxanonan
DE69026281T2 (de) Verfahren zur Reinigung und Isolierung von optisch aktivem Atenolol mit hoher Ausbeute
DD142713A1 (de) Verfahren zur herstellung von lysergol-derivaten
DE10311850A1 (de) Verfahren zur Herstellung von Vinpocetin
EP0004919A1 (de) Verfahren zur Herstellung von N,N,N',N'-Tetraacetyl-ethylendiamin
DD296924A5 (de) Antipoden-trennungsverfahren fuer 3r(3-carboxybenzyl)-6-(5-fluor-2-benzothiazolye) methoxy-4r-chromanol
EP1048663A1 (de) Verfahren zur Herstellung von L-Ascorbinsäure
EP0293753A2 (de) Verfahren zur Herstellung von E-2-Propyl-2-pentensäure und physiologisch verträglichen Salzen derselben
DE2922519A1 (de) Verfahren zum trennen von gemischen aus 3- und 4-nitrophthalsaeure
DE3051036C2 (ja)
DE2350610C3 (de) DL-Lithiumpantoat, D (+)-üthiumpantoat, L (-)-Lithiumpantoat und Verfahren zur Herstellung der optischen Antipoden des Pantolactons
DE2362687C3 (de) Verfahren zur Gewinnung der optischen Isomeren des Penicillamins
DE69015907T2 (de) Verfahren zur optischen Trennung von Dropropizin.
DE2436686A1 (de) Zerlegung von racemischem reticulin und racemisierung seiner enantiomeren
DE69229017T2 (de) Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung
EP0461541B1 (de) Verfahren zur Racematspaltung von 2,2-Dimethylcyclopropancarbonsäure
EP0174624A1 (de) Verfahren zur Herstellung von Milchsäureestern
WO2000018715A1 (de) VERFAHREN ZUR DRUCKLOSEN HERSTELLUNG VON α,α-DIMETHYLPHENYLESSIGSÄURE AUS α,α-DIMETHYLBENZYLCYANID
EP0200187B1 (de) Verfahren zur Herstellung von 2-Hydroxy-dibenzofuran-3-carbonsäure bzw. deren Alkalisalzen
DE19846448A1 (de) Verfahren zur Herstellung von oral aktivem Cephalosporin-Antibiotikum - Cefixim
DE3543021A1 (de) Verbesserte verfahren zur herstellung von d-threo-1-(p-methylsulfonylphenyl) -2-dichloracetamido-propandiol-1,3-(thiamphenicol) sowie verwendung geeigneter zwischenprodukte
DE1618289B2 (de) Salz des Dehydroabietylamins mit D- und L-alpha, gamma -Dihydroxy beta, beta-dimethylbuttersäure
DE69835508T2 (de) Verfahren zur herstellung von 2-(omega-alkoxycarbonylalkanoyl)-4-butanoliden,omega-hydroxy-(omega-3)-keto-fettsäureestern und ihrer derivate

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee